Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Dermatology
Search Medical Condition
Scalp Disorders Clinical Trials
A listing of Scalp Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (9) clinical trials
A phase 3, multi-center, randomized, placebo controlled, double-blind, study of the efficacy and safety of apremilast (CC-1004) in subjects with moderate to severe plaque psoriasis of the scalp.
Otezla vs. Placebo for 16 weeks, 2:1 Open label week 16-32 4 week followup
A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis
This study will be conducted to evaluate the therapeutic bioequivalence of a TEST formulation of calcipotriene hydrate and betamethasone dipropionate topical suspension 0.005%/0.064% to the RLD.
Scalp Psoriasis
Scalp Psoriasis Research Study This study evaluates an investigational topical medication for Scalp Psoriasis.
Scalp psoriasis
We are conducting a research study evaluating the safety and effectiveness of an investigational shampoo for scalp psoriasis. Qualified participants will receive study related exams and study medication at no charge. Please contact us today!
Scalp Psoriasis
A Random, Double- blind, Parallel-group, Vehicle -controlled, Multicenter Study Comparing TOLMAR Calcipotriene Hydrate and Betamethasone Diproprionate Topical Suspension 0.005%0.064% to Reference Listed Drug in the Treatment of Scalp Psoriasis.
Scalp Psoriasis?
At least 18 years of age Mild to severe psoriasis Only three visits Up to $150 for time and travel
A multi-center, double-blind, randomized, vehicle-controlled, parallel-group study to compare Perrigo UK FINCO ingenol mebutate topic Gel 0.015% to Leo Pharma Inc. Picato Topical Gel 0.015% (Ingenol Mebutate Topical Gel 0.015%), and both active treatments to a vehicle control in the treatment of actinic keratosis on the head region (face or scalp)
This is a 8 week study with 4 visits for treatment of actinic keratosis with a topical medication.
A national, multi-center, randomized, double-blind, 4 arm, 8 week study in subjects with psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs)
Patient Inclusion Criteria: 18+ years of age Diagnosis of stable plaque psoriasis Mild to moderate on trunk and/or limbs Patient Exclusion Criteria: Current diagnosis of guttate, erythrodermic or pustular psoriasis
Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Timeframe Collection of DNA for discovery cohort until 05/2016 Data analysis until 12/2014 for pyoderma gangrenosum, until 12/2016 for other NMID Report and data presentation early 2015 for PG, 2017 for other NMID
